Methyldopa

甲基多巴

Report date: 2023/04/10 09:54:34
NME

Base Information

Drug NameMethyldopa
Drug Alias NameMethyldopumAldometDopegytMK-351IMT-001 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors alpha-2 agonists
TargetsAdrenergic receptors alpha-2
Therapy Area/IndicationsDiabetes Mellitus, Type 1HypertensionPre-Eclampsia
Global Approved IndicationsHypertension
Approved Indications in ChinaHypertension
Original Approved Country/TerritoryUnited States
Original Approved Date1962/12/20
Country/TerritoryUnited StatesHong KongMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesImmunoMolecular Therapeutics IncHunan Er-Kang Pharmaceutical Co Ltd
Inactive CompaniesMerck & Co IncIsfahan University Of Medical SciencesNational Institute Of Diabetes And Digestive And Kidney Diseases +[4] 
Active IndicationsDiabetes Mellitus, Type 1Hypertension
Inactive IndicationsPre-Eclampsia

Other Information

ATC CodeC02AB
Related LinksWikipediaDrugBankKEGG